About InNeuroCo
InNeuroCo is a company based in Sunrise (United States) founded in 2014 by Marc Litzenberg and Daniel Sablyak was acquired by Integer in October 2023.. InNeuroCo has raised $1.51 million across 3 funding rounds from investors including Integer. The company has 99 employees as of December 31, 2022. InNeuroCo offers products and services including Catheter Solutions and Medical Devices. InNeuroCo operates in a competitive market with competitors including Huake Precision (Beijing) Medical Technology, Q’Apel Medical, Zeta Surgical, ClaroNav and Impulse Monitoring, among others.
- Headquarter Sunrise, United States
- Employees 99 as on 31 Dec, 2022
- Founders Marc Litzenberg, Daniel Sablyak
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inneuroco, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InNeuroCo
InNeuroCo offers a comprehensive portfolio of products and services, including Catheter Solutions and Medical Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops innovative catheters for brain aneurysm treatments.
Creates life-saving tools for neurovascular procedures.
Unlock access to complete
Product Management Team
3 people
QC Team
1 people
Operations Team
1 people
Principal Team
1 people
Document Team
1 people
Unlock access to complete
Funding Insights of InNeuroCo
InNeuroCo has successfully raised a total of $1.51M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $800.01 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $800,008
-
First Round
First Round
(02 Jan 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Debt – Conventional - InNeuroCo | Valuation |
investors |
|
| Jun, 2015 | Amount | Seed - InNeuroCo | Valuation |
investors |
|
| Jan, 2015 | Amount | Seed - InNeuroCo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InNeuroCo
InNeuroCo has secured backing from 1 investor. Prominent investors backing the company include Integer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical device components are developed and manufactured for healthcare markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InNeuroCo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InNeuroCo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inneuroco Comparisons
Competitors of InNeuroCo
InNeuroCo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Huake Precision (Beijing) Medical Technology, Q’Apel Medical, Zeta Surgical, ClaroNav and Impulse Monitoring, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| domain | founded_year | HQ Location |
Medical devices for neurovascular disorder treatments are provided.
|
|
| domain | founded_year | HQ Location |
AI-based navigation and robotics systems for surgeries are developed.
|
|
| domain | founded_year | HQ Location |
Medical 3D visualization and surgical navigation solutions are developed.
|
|
| domain | founded_year | HQ Location |
Intraoperative neurophysiological monitoring is conducted for spinal and brain surgeries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inneuroco
Frequently Asked Questions about InNeuroCo
When was InNeuroCo founded?
InNeuroCo was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is InNeuroCo located?
InNeuroCo is headquartered in Sunrise, United States. It is registered at Sunrise, Florida, United States.
Who is the current CEO of InNeuroCo?
Marc Litzenberg is the current CEO of InNeuroCo. They have also founded this company.
Is InNeuroCo a funded company?
InNeuroCo is a funded company, having raised a total of $1.51M across 3 funding rounds to date. The company's 1st funding round was a Seed of $925K, raised on Jan 02, 2015.
How many employees does InNeuroCo have?
As of Dec 31, 2022, the latest employee count at InNeuroCo is 99.
What does InNeuroCo do?
InNeuroCo is a developer of devices for neurovascular surgeries. The companys Super Distal Access (SDA) is FDA 510(k) cleared (K161262) and it is indicated for the introduction of interventional devices into the peripheral and neuro vasculature. The companys Long Sheath also received FDA 510(k) clearance (K152876) and is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature. The company has partnered with Codman Neuro for the distribution of its intermediate catheter range.
Who are the top competitors of InNeuroCo?
InNeuroCo's top competitors include Huake Precision (Beijing) Medical Technology, Zeta Surgical and Q’Apel Medical.
What products or services does InNeuroCo offer?
InNeuroCo offers Catheter Solutions and Medical Devices.
Who are InNeuroCo's investors?
InNeuroCo has 1 investor. Key investors include Integer.